Detailed peptide and compound profiles connecting mechanisms, published studies and evidence limits with the questions that matter when reviewing research materials.
Human trial evidenceRetatrutide
GLP-1, GIP and glucagon receptor agonism
A research profile of triple-receptor agonism, with a close reading of a published obesity trial and the documentation needed to connect a laboratory material to the molecule being discussed.
Read Retatrutide profile →Human trial evidenceTirzepatide
GIP and GLP-1 receptor agonism
Understand dual-receptor research, the difference between obesity and diabetes trial populations, and why results must be read with the actual comparator and endpoint.
Read Tirzepatide profile →Human trial evidenceSemaglutide
GLP-1 receptor agonism
A guide to reading GLP-1 research, separating molecule-level findings from formulation-specific results, and evaluating identity and content records for research procurement.
Read Semaglutide profile →Human trial evidenceCagrilintide
Long-acting amylin analogue
Explore amylin-related research, distinguish cagrilintide-alone evidence from combination studies, and understand which batch records to request.
Read Cagrilintide profile →Cell and tissue-model evidenceBPC-157
Tendon-cell response and migration studies
Read the experimental literature without confusing cell movement, tissue-model observations and demonstrated clinical recovery. Includes identity and documentation questions for research materials.
Read BPC-157 profile →Analytical evidenceTB-500
Thymosin beta-4-related identity questions
Why the exact peptide identity matters when reading thymosin-related research, and what an analytical detection study can—and cannot—establish.
Read TB-500 profile →Cell and animal evidenceGHK-Cu
Copper-binding tripeptide and extracellular-matrix studies
Understand what copper-peptide experiments measured, how GHK differs from GHK-Cu, and why laboratory matrix findings do not establish a finished skincare product's performance.
Read GHK-Cu profile →Preclinical and observational evidenceMOTS-c
Mitochondrial-derived peptide and metabolic signalling
Explore mitochondrial peptide research while keeping human exercise observations separate from peptide-intervention experiments in mice.
Read MOTS-c profile →Human pilot and precursor studiesNAD+
Nicotinamide adenine dinucleotide metabolism
Separate NAD+ from its precursors and distinguish metabolite changes from demonstrated clinical benefit when reading cellular-energy research.
Read NAD+ profile →Human randomized trial evidenceSS-31 / Elamipretide
Mitochondrial-targeted peptide research
Read early and later elamipretide trials together, including a phase 3 study that did not meet its primary efficacy endpoints in primary mitochondrial myopathy.
Read SS-31 / Elamipretide profile →Preclinical and human trial evidenceIpamorelin
Ghrelin-receptor agonism and GH-secretagogue research
Distinguish receptor pharmacology, hormone measurements and clinical outcomes, with an example from a postoperative gastrointestinal trial.
Read Ipamorelin profile →Preclinical and early human evidenceCJC-1295 with DAC
Long-acting GHRH analogue and albumin-binding design
Understand the long-acting CJC-1295 research and why its findings should not automatically be assigned to products labelled without DAC or to combination blends.
Read CJC-1295 with DAC profile →Human randomized trial evidenceTesamorelin
GHRH-analogue research in defined clinical populations
Read tesamorelin evidence with its original population and body-composition endpoints, separating visceral-fat measurements from general weight-loss claims.
Read Tesamorelin profile →Human randomized trial evidenceThymosin Alpha-1
Immunomodulatory research in sepsis studies
Evaluate thymosin alpha-1 evidence through trial design, clinical endpoints and uncertainty, rather than broad claims about boosting immunity.
Read Thymosin Alpha-1 profile →Cell and mouse-model evidenceKPV
Peptide transport and inflammatory signalling
Explore KPV transport research, distinguish experimental colitis from human clinical outcomes, and learn which identity records to request.
Read KPV profile →Human-origin cell-culture evidenceEpithalon
Telomerase and telomere measurements
Read Epithalon, also searched as Epitalon, through the distinction between cultured-cell findings, telomere measurements and claims about human longevity.
Read Epithalon profile →Rat transcriptome researchSemax
Gene-expression responses in cerebral ischaemia models
Understand how Semax gene-expression studies are designed, what an ischaemia model measures, and why those results cannot be read as proof of enhanced cognition.
Read Semax profile →Rat molecular-endpoint evidenceSelank
Neurotransmission-related gene-expression research
Explore Selank research with attention to the measured endpoint: gene expression, neurotransmission hypotheses and the limits of translating animal findings.
Read Selank profile →Human randomized biomarker trialGlutathione
Glutathione stores and oxidative-stress measurements
Distinguish reduced and oxidized glutathione, read compartment-specific biomarker results, and keep formulation evidence separate from broad health claims.
Read Glutathione profile →Human intervention evidenceL-Carnitine
Muscle carnitine and exercise fuel metabolism
Read L-carnitine metabolism research with its actual comparator, co-intervention and sample measurements, rather than treating all carnitine products as equivalent.
Read L-Carnitine profile → No matching profiles. Try another term or choose All profiles.
Educational summaries for laboratory research. No personal-use dosing or treatment recommendations. The library reviews selected publications and does not claim exhaustive coverage.